Option Care Health (NASDAQ:OPCH) Upgraded at The Goldman Sachs Group

Option Care Health (NASDAQ:OPCH) was upgraded by equities research analysts at The Goldman Sachs Group to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

Several other research firms also recently issued reports on OPCH. Truist Financial set a $30.00 price objective on shares of Option Care Health in a report on Friday, May 1st. Stephens set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. JPMorgan Chase & Co. reduced their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Weiss Ratings downgraded shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.54.

Option Care Health Price Performance

NASDAQ OPCH opened at $20.08 on Monday. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The company has a fifty day simple moving average of $24.17 and a 200 day simple moving average of $29.48. The company has a market cap of $3.15 billion, a P/E ratio of 15.57, a P/E/G ratio of 1.14 and a beta of 0.67. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. Option Care Health’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, sell-side analysts predict that Option Care Health will post 1.64 EPS for the current year.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of Option Care Health stock in a transaction on Monday, May 4th. The stock was purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the acquisition, the director directly owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan acquired 24,154 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was acquired at an average price of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director owned 73,383 shares in the company, valued at approximately $1,518,294.27. This represents a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 in the last ninety days. Company insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds have recently made changes to their positions in OPCH. Royal Bank of Canada raised its stake in shares of Option Care Health by 20.7% in the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after buying an additional 39,661 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Option Care Health by 162.6% in the 1st quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after buying an additional 25,777 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health during the 1st quarter worth about $208,000. Invesco Ltd. increased its position in shares of Option Care Health by 2.7% during the 2nd quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after purchasing an additional 7,678 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Option Care Health by 528.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.